Mark Harrigan is a graduate of the University of Washington School of Medicine in Seattle. He did a residency in neurosurgery at the University of Michigan and a fellowship in interventional neurosurgery at the University of Buffalo under the direction of L. Nelson Hopkins. Presently he is Professor of Neurosurgery, Neurology and Radiology at the University of Alabama, Birmingham (UAB). His clinical focus is on vascular and interventional neurosurgery and his research emphasis is on cerebrovascular clinical trials. He is the UAB site principal investigator for the CREST 2, MISTIE III and MyRIAD studies, among others, and his research passion is the management of blunt traumatic cerebrovascular injury. Outside of work his interests include motorcycling, running and dry wit.